• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pulmonary hypertension in a patient with hereditary haemorrhagic telangiectasia.遗传性出血性毛细血管扩张症患者的肺动脉高压
BMJ Case Rep. 2013 Feb 1;2013:bcr2012008352. doi: 10.1136/bcr-2012-008352.
2
A case of primary ciliary dyskinesia with pulmonary arterial hypertension responding to oral sildenafil.一例原发性纤毛运动障碍合并肺动脉高压患者口服西地那非有效。
J Assoc Physicians India. 2011 Nov;59:738-40.
3
Successful bosentan therapy for pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia.波生坦成功治疗与遗传性出血性毛细血管扩张症相关的肺动脉高压。
Heart Vessels. 2011 Mar;26(2):231-4. doi: 10.1007/s00380-010-0079-z. Epub 2010 Dec 4.
4
Sildenafil and steroid therapy effectively improved POEMS syndrome-associated pulmonary arterial hypertension.西地那非和类固醇疗法有效改善了POEMS综合征相关的肺动脉高压。
Int J Hematol. 2010 Dec;92(5):774-6. doi: 10.1007/s12185-010-0722-6. Epub 2010 Dec 4.
5
Bosentan therapy for pulmonary arterial hypertension associated with hereditary haemorrhagic telangiectasia.波生坦治疗与遗传性出血性毛细血管扩张症相关的肺动脉高压
Eur J Clin Invest. 2006 Sep;36 Suppl 3:71-2. doi: 10.1111/j.1365-2362.2006.01683.x.
6
The intersection of genes and environment: development of pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia and stimulant exposure.基因与环境的交集:遗传性出血性毛细血管扩张症合并兴奋剂暴露患者肺动脉高压的发生。
Chest. 2012 Jun;141(6):1598-1600. doi: 10.1378/chest.11-1402.
7
Screening and treating pulmonary arterial hypertension in a tertiary hospital-based multidisciplinary clinic: the first 200 patients.在一家三级医院多学科诊所中筛查和治疗肺动脉高压:前 200 例患者。
Intern Med J. 2013 Jan;43(1):32-7. doi: 10.1111/j.1445-5994.2011.02624.x.
8
Pulmonary vascular complications of hereditary haemorrhagic telangiectasia.遗传性出血性毛细血管扩张症的肺血管并发症
Curr Opin Pulm Med. 2014 Sep;20(5):421-8. doi: 10.1097/MCP.0000000000000076.
9
The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease.西地那非治疗伴有不同类型先天性心脏病的肺动脉高压患者的疗效和安全性。
Clin Cardiol. 2011 Aug;34(8):513-8. doi: 10.1002/clc.20917. Epub 2011 Jun 15.
10
Sildenafil in idiopathic pulmonary fibrosis.西地那非治疗特发性肺纤维化
N Engl J Med. 2010 Nov 25;363(22):2169; author reply 2170-1. doi: 10.1056/NEJMc1010408.

引用本文的文献

1
Pulmonary arteriovenous malformations: diagnostic and treatment characteristics.肺动静脉畸形:诊断和治疗特征。
J Bras Pneumol. 2019 Jun 19;45(4):e20180137. doi: 10.1590/1806-3713/e20180137.
2
Pulmonary arteriovenous malformations in children with hereditary hemorrhagic telangiectasia: a longitudinal study.遗传性出血性毛细血管扩张症患儿的肺动静脉畸形:一项纵向研究
Pulm Circ. 2018 Jul-Sep;8(3):2045894018786696. doi: 10.1177/2045894018786696. Epub 2018 Jun 19.
3
The clinical characteristics and long-term prognosis of pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症相关肺动脉高压的临床特征及长期预后
Pulm Circ. 2018 Apr-Jun;8(2):2045894018759918. doi: 10.1177/2045894018759918. Epub 2018 Feb 26.
4
Optimal management of hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症的优化管理
J Blood Med. 2014 Oct 15;5:191-206. doi: 10.2147/JBM.S45295. eCollection 2014.

本文引用的文献

1
Pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症患者的肺动脉高压。
Arch Bronconeumol. 2013 Mar;49(3):119-21. doi: 10.1016/j.arbres.2012.04.021. Epub 2012 Jun 22.
2
The intersection of genes and environment: development of pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia and stimulant exposure.基因与环境的交集:遗传性出血性毛细血管扩张症合并兴奋剂暴露患者肺动脉高压的发生。
Chest. 2012 Jun;141(6):1598-1600. doi: 10.1378/chest.11-1402.
3
Successful bosentan therapy for pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia.波生坦成功治疗与遗传性出血性毛细血管扩张症相关的肺动脉高压。
Heart Vessels. 2011 Mar;26(2):231-4. doi: 10.1007/s00380-010-0079-z. Epub 2010 Dec 4.
4
Hereditary hemorrhagic telangiectasia: diagnosis and management.遗传性出血性毛细血管扩张症:诊断与管理。
Am Fam Physician. 2010 Oct 1;82(7):785-90.
5
Hereditary hemorrhagic telangiectasia: rare cause of pulmonary hypertension?遗传性出血性毛细血管扩张症:肺动脉高压的罕见病因?
Arq Bras Cardiol. 2010 Mar;94(3):e34-6, e94-6. doi: 10.1590/s0066-782x2010000300026.
6
[Pulmonary hypertension in hereditary haemorrhagic teleangiectasia].[遗传性出血性毛细血管扩张症中的肺动脉高压]
Pneumologie. 2009 Nov;63(11):669-74. doi: 10.1055/s-0029-1215111. Epub 2009 Sep 29.
7
Guidelines for the diagnosis and treatment of pulmonary hypertension.肺动脉高压诊断与治疗指南。
Eur Respir J. 2009 Dec;34(6):1219-63. doi: 10.1183/09031936.00139009. Epub 2009 Sep 12.
8
Updated clinical classification of pulmonary hypertension.肺动脉高压的更新临床分类。
J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S43-S54. doi: 10.1016/j.jacc.2009.04.012.
9
The pulmonary vascular complications of hereditary haemorrhagic telangiectasia.遗传性出血性毛细血管扩张症的肺血管并发症
Eur Respir J. 2009 May;33(5):1186-94. doi: 10.1183/09031936.00061308.
10
BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia.一名患有肺动脉高压且疑似遗传性出血性毛细血管扩张症患者的骨形态发生蛋白受体2(BMPR2)突变
Am J Med Genet A. 2008 Oct 1;146A(19):2551-6. doi: 10.1002/ajmg.a.32468.

遗传性出血性毛细血管扩张症患者的肺动脉高压

Pulmonary hypertension in a patient with hereditary haemorrhagic telangiectasia.

作者信息

Chadha Davinder, Handa Ajay, Kumar Abhishek

机构信息

Department of Cardiology, MH, CTC, Pune, Maharashtra, India.

出版信息

BMJ Case Rep. 2013 Feb 1;2013:bcr2012008352. doi: 10.1136/bcr-2012-008352.

DOI:10.1136/bcr-2012-008352
PMID:23378554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3604189/
Abstract

A young male patient reported for evaluation of progressive easy fatigability, accompanied by a recent history of recurrent haemoptysis. His clinical examination was unremarkable except for evidence of pulmonary arterial hypertension (PAH). Routine investigations (haemogram, coagulogram, serological tests for connective tissue disorders and a sputum Ziehl Neelsen stain for acid-fast bacilli) were normal. Two-dimensional echocardiography suggested PAH (pulmonary artery systolic pressure-67 mm Hg), whereas the 64-slice spiral CT pulmonary angiogram showed a dilated main pulmonary artery along with bilateral arteriovenous malformations. Cardiac catheterisation performed subsequently confirmed the presence of PAH. On the basis of the above findings, a diagnosis of hereditary haemorrhagic telangiectasia (HHT) complicated with PAH was made, and the patient was started on oral sildenafil therapy to which he responded well. This rare complication of HHT, which requires a high degree of suspicion for diagnosis, is discussed.

摘要

一名年轻男性患者因进行性易疲劳前来评估,伴有近期反复咯血病史。除肺动脉高压(PAH)证据外,其临床检查无异常。常规检查(血常规、凝血功能、结缔组织病血清学检查及痰涂片抗酸染色找抗酸杆菌)均正常。二维超声心动图提示PAH(肺动脉收缩压67mmHg),而64层螺旋CT肺血管造影显示主肺动脉扩张伴双侧动静脉畸形。随后进行的心导管检查证实存在PAH。基于上述发现,诊断为遗传性出血性毛细血管扩张症(HHT)合并PAH,并开始给予患者口服西地那非治疗,患者反应良好。本文讨论了这种HHT的罕见并发症,其诊断需要高度怀疑。